|
OSMR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.601100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.144200E-03 |
| Normal-vs-Stage2 |
3.592600E-01 |
| Normal-vs-Stage3 |
2.755800E-04 |
| Normal-vs-Stage4 |
6.475400E-03 |
| Stage1-vs-Stage2 |
8.159200E-03 |
| Stage1-vs-Stage3 |
9.149600E-02 |
| Stage1-vs-Stage4 |
1.563210E-01 |
| Stage2-vs-Stage3 |
2.579100E-04 |
| Stage2-vs-Stage4 |
2.701300E-03 |
| Stage3-vs-Stage4 |
9.192200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.75960000001496E-06 |
| Normal-vs-AfricanAmerican |
4.648400E-02 |
| Normal-vs-Asian |
5.962200E-02 |
| Caucasian-vs-AfricanAmerican |
4.734000E-01 |
| Caucasian-vs-Asian |
4.132800E-01 |
| AfricanAmerican-vs-Asian |
3.197400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.706400E-02 |
| Normal-vs-Female |
3.197500E-04 |
| Male-vs-Female |
6.223400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.404400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.896200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.008850E-01 |
| Normal-vs-Age(81-100Yrs) |
1.586610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.334200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.689400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.977600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.104800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.962000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.100600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.052300E-02 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
4.892500E-02 |
| Classical-VS-Normal |
2.92380000210812E-08 |
| Tall-VS-Follicular |
6.32759955543349E-10 |
| Tall-VS-Other |
2.563800E-03 |
| Tall-VS-Normal |
1.58302999999638E-05 |
| Follicular-VS-Other |
1.729790E-01 |
| Follicular-VS-Normal |
1.29110000468557E-08 |
| Other-VS-Normal |
2.180200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.800800E-01 |
| Normal-vs-N1 |
9.202200E-04 |
| N0-vs-N1 |
2.079900E-03 |
|
|
